Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
View/ Open
Published Version
https://doi.org/10.1186/s13073-017-0469-2Metadata
Show full item recordCitation
Liebenberg, Lenine J. P., Derseree Archary, Aida Sivro, and Douglas S. Kwon. 2017. “Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention.” Genome Medicine 9 (1): 74. doi:10.1186/s13073-017-0469-2. http://dx.doi.org/10.1186/s13073-017-0469-2.Abstract
Editorial summary Advances in molecular tools to characterize the microbiome have led to the discovery of unique roles for microbes in human disease. Findings that the female genital microbiome can influence HIV acquisition and prevention emphasize the importance of microbiome analysis in clinical trials that assess the efficacy of HIV prevention interventions.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561602/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375026
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)